Proteome completes TB milestone
Tuesday, 17 June, 2008
Proteome Systems (ASX: PXL) has completed the preparations necessary to conduct a feasibility test of its collaborative agreement with Becton Dickinson (BD) to develop a new tuberculosis test.
PXL has defined a sample processing strategy for a proposed in-field diagnostics test. This achievement will trigger a further payment from BD once the feasibility stage has been completed.
If the feasibility tests are successful, BD will pay PXL both up-front and milestone payments for the right to co-develop and market the new test.
The tests promise to be much more accurate and rapid than the current method of testing for tuberculosis, sputum spear microscopy, which hasn't changed significantly in nearly 130 years.
Overuse of inhalers can increase heart attack risk
Overuse of reliever inhalers is associated with higher risks of developing and dying from...
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
